Cytokines in immunity and allograft rejection

Critical Reviews in Immunology

Volumn 22, Issue 4, 2002, Pages 269-279

  Benjamin III, Louis C ^a   Allan, James S ^a   Madsen, Joren C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Acute rejection; Chronic rejection; Cytokines; Transplantation

Indexed keywords

ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR; ERYTHROPOIETIN RECEPTOR; GAMMA INTERFERON; INTERFERON; INTERFERON RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LYMPHOTOXIN; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TYROSINE KINASE RECEPTOR;

ADAPTATION; ANTIGEN RECOGNITION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CHEMOTAXIS; CYTOKINE RELEASE; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MICROENVIRONMENT; MOLECULAR BIOLOGY; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW;

ANIMALS; CYTOKINES; GRAFT REJECTION; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036960286     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Leonard WJ. Type I cytokines and interferons and their receptors. In: Paul WE, ed. Fundamental Immunology. Philadelphia: Lippincott-Raven Publishers, 1999: 741-774.
2. Dumonde DC, Wolstencroft RA, Panayi GS, Matthew M, Morley J, Howson WT. "Lymphokines:" non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature 1969; 224:38-42.
3. Cohen S, Bigazzi PE, Yoshida T. Commentary. Similarities of T cell function in cell-mediated immunity and antibody production. Cell Immunol 1974; 12:150-159.
4. Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A 1990; 87:6934-6938.
5. Fanslow WC, Clifford KN, Park LS, Rubin AS, Voice RF, Beckmann MP, Widmer MB. Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor. J Immunol 1991; 147:535-540.
6. Langer J, Garotta G, Pestka S. Interferon receptors. Biotherapy 1996; 8:163-174.
7. Abbas AK, Lichtman AH, Pober JS. Cellular and Molecular Immunology. Philadelphia: W. B. Saunders, 2000.
8. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 1975; 72:3666-3670.
9. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87:2095-2147.
10. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997; 15:675-705.
11. Orange JS, Wang B, Terhorst C, Biron CA. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 1995; 182:1045-1056.
12. Moore KW, O'Garra A, de Waal MR, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11:165-190.
13. Bretscher P, Cohn M. A theory of self-nonself discrimination. Science 1970; 169:1042-1049.
14. Ferrari-Lacraz S, Zheng XX, Kim YS, Li Y, Maslinski W, Li XC, Strom TB. An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection. J Immunol 2001; 167:3478-3485.
15. Banks TA, Rouse BT, Kerley MK, Blair PJ, Godfrey VL, Kuklin NA, Bouley DM, Thomas J, Kanangat S, Mucenski ML. Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J Immunol 1995; 155:1685-1693.
16. Coffman RL, Carty J. AT cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma. J Immunol 1986; 136:949-954.
17. Punnonen J, Aversa G, Cocks BG, McKenzie AN, Menon S, Zurawski G, de Waal Malefyt R, de Vries JE. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A 1993; 90:3730-3734.
18. Bagley J, Sawada T, Wu Y, Iacomini J. A critical role for interleukin 4 in activating alloreactive CD4 T cells. Nat Immunol 2000; 1:257-261.
19. Goes N, Urmson J, Hobart M, Halloran PF. The unique role of interferon-gamma in the regulation of MHC expression on arterial endothelium. Transplantation 1996; 62:1889-1894.
20. McCartney-Francis NL, Wahl SM. Transforming growth factor beta: a matter of life and death. J Leukoc Biol 1994; 55:401-409.
21. Van der Hoeven JAB, Ploeg RJ. Effects of brain death on donor organ viability. Curr Opin Organ Transplant 2001; 6:75-82.
22. Pratschke J, Wilhelm MJ, Kusaka M, Beato F, Milford EL, Hancock WW, Tilney NL. Accelerated rejection of renal allografts from brain-dead donors. Ann Surg 2000; 232:263-271.
23. Wilhelm MJ, Pratschke J, Beato F, Taal M, Kusaka M, Hancock WW, Tilney NL. Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation 2000; 102:2426-2433.
24. Daemen MA, van't Veer C, Wolfs TG, Buurman WA. Ischemia/reperfusion-induced IFN-gamma up-regulation:involvement of IL-12 and IL-18. J Immunol 1999; 162:5506-5510.
25. Mal H, Dehoux M, Sleiman C, Boczkowski J, Leseche G, Pariente R, Fournier M. Early release of proinflammatory cytokines after lung transplantation. Chest 1998; 113:645-651.
26. Hancock WW. Analysis of intragraft effector mechanisms associated with human renal allograft rejection: immunohistological studies with monoclonal antibodies. Immunol Rev 1984; 77:61-84.
27. Campbell JJ, Hedrick J, Zlotnik A, Siani MA, Thompson DA, Butcher EC. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 1998; 279:381-384.
28. Gao W, Topham PS, King JA, Smiley ST, Csizmadia V, Lu B, Gerard CJ, Hancock WW. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest 2000; 105:35-44.
29. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9:271-296.
30. Misumi M, Mori K, Yamaguchi Y, Naito M, Takeya M, Takahashi K, Ogawa M. Immunohistochemical characterization of infiltrating macrophages in rejecting liver allografts in the rat. Transplantation 1991; 52:753-754.
31. Yamamoto R, Kinoshita H, Kinoshita Y, Mizoguchi S, Inoue K, Kishi A. Immunohistochemical aspects of acute rejection of the allografted rat lung. Transplantation 1990; 49:631-632.
32. Halloran PF, Schlaut J, Solez K, Srinivasa NS. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 1992; 53:550-555.
33. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991; 174:493-496.
34. McLean AG, Hughes D, Welsh KI, Gray DW, Roake J, Fuggle SV, Morris PJ, Dallman MJ. Patterns of graft infiltration and cytokine gene expression during the first 10 days of kidney transplantation. Transplantation 1997; 63:374-380.
35. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992; 53:1281-1294.
36. Dallman MJ. Cytokines as mediators of organ graft rejection and tolerance. Curr Opin Immunol 1993; 5:788-793.
37. Wu CJ, Lovett M, Wong-Lee J, Moeller F, Kitamura M, Goralski TJ, Billingham ME, Starnes VA, Clayberger C. Cytokine gene expression in rejecting cardiac allografts. Transplantation 1992; 54:326-332.
38. Dugre FJ, Gaudreau S, Belles-Isles M, Houde I, Roy R. Cytokine and cytotoxic molecule gene expression determined in peripheral blood mononuclear cells in the diagnosis of acute renal rejection. Transplantation 2000; 70:1074-1080.
39. Baan CC, Knoop CJ, van Gelder T, Holweg CT, Niesters HG, Smeets TJ, van der Ham F, Zondervan PE, Maat LP, Balk AH, Weimar W. Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantation. Transplantation 1999; 67:870-876.
40. Auchincloss H, Lee RS, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci U S A 1993; 90:3373-3377.
41. Benichou G. Direct and indirect antigen recognition: the pathways to allograft immune rejection. Front Biosci 1999; 4:D476-D480.
42. Vella JP, Magee C, Vos L, Womer K, Rennke H, Carpenter CB, Hancock W, Sayegh MH. Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides. Transplantation 1999; 67:1523-1532.
43. Womer KL, Stone JR, Murphy B, Chandraker A, Sayegh MH. Indirect allorecognition of donor class I and II major histocompatibility complex peptides promotes the development of transplant vasculopathy. J Am Soc Nephrol 2001; 12:2500-2506.
44. Lee RS, Yamada K, Houser SL, Womer KL, Maloney ME, Rose HS, Sayegh MH, Madsen JC. Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy. Proc Natl Acad Sci U S A 2001; 98:3276-3281.
45. Vella JP, Spadafora-Ferreira M, Murphy B, Alexander SI, Harmon W, Carpenter CB, Sayegh MH. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997; 64:795-800.
46. Najafian N, Salama AD, Fedoseyeva EV, Benichou G, Sayegh MH. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 2002; 13:252-259.
47. Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Cook HT, Lechler RI. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy. J Immunol 2001; 167:7199-7206.
48. Cecka JM. The UNOS Scientific Renal Transplant Registry - ten years of kidney transplants. Clin Transpl 1997; 1-14.
49. SivaSai KS, Smith MA, Poindexter NJ, Sundaresan SR, Trulock EP, Lynch JP, Cooper JD, Patterson GA, Mohanakumar T. Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Transplantation 1999; 67:1094-1098.
50. Smith MA, Jaramillo A, SivaSai KS, Naziruddin B, Kaleem Z, Patterson GA, Mohanakumar T. Indirect recognition and antibody production against a single mismatched hla-A2-transgenic molecule precede the development of obliterative airway disease in murine heterotopic tracheal allografts1. Transplantation 2002; 73:186-193.
51. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations. Am J Pathol 1994; 144:260-274.
52. Tellides G, Tereb DA, Kirkiles-Smith NC, Kim RW, Wilson JH, Schechner JS, Lorber MI, Pober JS. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 2000; 403:201-211.